Keyphrases
Tumor Immunity
100%
Antigen-specific
100%
Chimeric Protein
100%
Prostate-specific Antigen
100%
Heat Shock Proteins
100%
Plasmid DNA Vaccine
100%
CD8+ Cytotoxic T Lymphocytes
100%
Plasmid
37%
Heat Shock Protein 70 (HSP70)
37%
Cytotoxic T Lymphocytes
25%
Tumor
12%
Mycobacterium Tuberculosis (M. tb)
12%
Escherichia Coli
12%
Human Prostate
12%
Tumor Challenge
12%
Cytotoxic T Cell Response
12%
Protein-based Vaccine
12%
Plasmid DNA (pDNA)
12%
Tumor Antigen
12%
Vector Encoding
12%
Hsp65
12%
DNA Vaccine
12%
Mycobacterium Bovis
12%
DnaK
12%
Fusion Partner
12%
DNA-based Vaccines
12%
Biochemistry, Genetics and Molecular Biology
Cytotoxic T Cell
100%
Heat Shock Protein
100%
Plasmid
100%
Fusion Protein
100%
Prostate-Specific Antigen
100%
CD8
100%
Mouse
50%
Hsp70
37%
Escherichia coli
12%
Antigen Specificity
12%
Tumor Antigen
12%
Mycobacterium Tuberculosis
12%
Immunology and Microbiology
Cytotoxic T Cell
100%
CD8
100%
Plasmid
100%
DNA Vaccine
100%
Heat Shock
100%
Prostate Specific Antigen
100%
Mouse
50%
Vaccine Efficacy
12%
Mycobacterium Tuberculosis
12%
Escherichia coli
12%
Antigen Specificity
12%
Tumor Antigen
12%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Specific Antigen
100%
CD8 Antigen
100%
Heat Shock Protein
100%
DNA Vaccine
100%
Plasmid DNA
100%
Chimeric Protein
100%
Mouse
50%
Neoplasm
25%
Escherichia coli
12%
Mycobacterium Tuberculosis
12%
Tumor Antigen
12%